These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Chin AI; Yeun JY Am J Kidney Dis; 2006 Apr; 47(4):697-712. PubMed ID: 16564950 [No Abstract] [Full Text] [Related]
6. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan. Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369 [TBL] [Abstract][Full Text] [Related]
7. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Kawanishi H; Kawaguchi Y; Fukui H; Hara S; Imada A; Kubo H; Kin M; Nakamoto M; Ohira S; Shoji T Am J Kidney Dis; 2004 Oct; 44(4):729-37. PubMed ID: 15384025 [TBL] [Abstract][Full Text] [Related]
9. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. Yamamoto R; Nakayama M; Hasegawa T; Miwako N; Yamamoto H; Yokoyami K; Ikeda M; Kato N; Hayakawa H; Takahashi H; Otsuka Y; Kawaguchi Y; Hosoya T Adv Perit Dial; 2002; 18():131-4. PubMed ID: 12402604 [TBL] [Abstract][Full Text] [Related]
10. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients. Alscher DM; Braun N; Biegger D; Fritz P Am J Kidney Dis; 2007 Mar; 49(3):452-61. PubMed ID: 17336707 [TBL] [Abstract][Full Text] [Related]
11. Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis. Moriishi M; Kawanishi H Adv Perit Dial; 2008; 24():56-9. PubMed ID: 18986002 [TBL] [Abstract][Full Text] [Related]
12. Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002. Nakayama M; Yamamoto H; Ikeda M; Hasegawa T; Kato N; Takahashi H; Otsuka Y; Yokoyama K; Yamamoto R; Kawaguchi Y; Hosoya T Adv Perit Dial; 2002; 18():144-8. PubMed ID: 12402607 [TBL] [Abstract][Full Text] [Related]
13. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model. Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012 [TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model. Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998 [TBL] [Abstract][Full Text] [Related]
15. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Shroff R; Stefanidis CJ; Askiti V; Edefonti A; Testa S; Ekim M; Kavaz A; Ariceta G; Bakkaloglu S; Fischbach M; Klaus G; Zurowska A; Holtta T; Jankauskiene A; Vondrak K; Vande Walle J; Schmitt CP; Watson AR; Nephrol Dial Transplant; 2013 Jul; 28(7):1908-14. PubMed ID: 23348882 [TBL] [Abstract][Full Text] [Related]
16. Proof-of-principle study to detect metabolic changes in peritoneal dialysis effluent in patients who develop encapsulating peritoneal sclerosis. Dunn WB; Summers A; Brown M; Goodacre R; Lambie M; Johnson T; Wilkie M; Davies S; Topley N; Brenchley P Nephrol Dial Transplant; 2012 Jun; 27(6):2502-10. PubMed ID: 22294777 [TBL] [Abstract][Full Text] [Related]
17. [Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal]. Nakayama M; Ikeda M; Katoh N; Hayakawa H; Numata M; Otsuka Y; Yamamoto R; Yamamoto H; Yokoyama K; Kubo H; Kawaguchi Y; Hosoya T Nihon Jinzo Gakkai Shi; 2002 May; 44(4):396-401. PubMed ID: 12073625 [TBL] [Abstract][Full Text] [Related]
18. [Encapsulating peritoneal sclerosis--a serious complication of peritoneal dialysis with not characteristic symptoms]. Kowalewska J; Lichodziejewska-Niemierko M; Liberek T; Mechlińska-Baczkowska J; Nałecz A; Jaśkiewicz K; Rutkowski B Wiad Lek; 2006; 59(5-6):419-21. PubMed ID: 17017495 [TBL] [Abstract][Full Text] [Related]